Rodriguez-Riascos Juan F, Vemulapalli Hema Srikanth, Muthu Padmapriya, Raman Aria, Prajapati Poojan, Iyengar Shruti, Iyengar Sumedh, El Masry Hicham, Valverde Arturo M, Srivathsan Komandoor
Division of Cardiovascular Diseases, Mayo Clinic Hospital, Phoenix, Arizona.
Department of Internal Medicine, Bridgeport Hospital, Yale New Haven Health, Bridgeport, Connecticut.
Heart Rhythm O2. 2025 Jan 10;6(4):424-433. doi: 10.1016/j.hroo.2024.12.015. eCollection 2025 Apr.
Pulmonary vein isolation (PVI) has demonstrated acceptable success rates; however, there is still potential for improvement. Pulmonary reconnection remains the main problem and the role of adjunctive strategies, such as repeat mapping to guide additional lesions to enhance durability of pulmonary vein isolation, remains uncertain.
This study aimed to evaluate the impact of post-PVI high-density remapping with guided incremental lesions on long-term recurrence-free survival.
This study included consecutive patients who underwent PVI between 2015 and 2023. Patients were divided into 2 groups based on whether they received post-PVI high-density remapping. Those in the remapping group with documented areas of incomplete ablation received incremental lesions to achieve complete ablation. The primary endpoint was recurrence-free survival.
A total of 588 patients, with a mean follow-up of 25.8 months, were included. Post-PVI remapping was performed in 243 patients, while 345 patients underwent conventional PVI. Post-PVI remapping with guided incremental lesions improved recurrence-free survival compared with conventional PVI (adjusted hazard ratio 0.75, 95% confidence interval [CI] 0.57-0.99, .04). This benefit was especially notable in patients with paroxysmal atrial fibrillation (hazard ratio 0.69, 95% CI 0.49-0.96, .027). Complication rates and procedure times were comparable between the 2 groups. For patients undergoing their first radiofrequency ablation, 1-year success was higher in those who underwent PVI remapping (adjusted odds ratio 1.70, 95% CI 1.04-2.77, .03). However, long-term outcomes were comparable between the 2 groups.
Postablation mapping effectively identifies and addresses proarrhythmic foci, potentially reducing atrial fibrillation recurrence and improving patient outcomes.
肺静脉隔离(PVI)已显示出可接受的成功率;然而,仍有改进的潜力。肺静脉重新连接仍然是主要问题,辅助策略(如重复标测以指导额外消融灶以提高肺静脉隔离的持久性)的作用仍不明确。
本研究旨在评估PVI后高密度重新标测及引导下递增消融灶对长期无复发生存率的影响。
本研究纳入2015年至2023年间连续接受PVI的患者。根据是否接受PVI后高密度重新标测将患者分为两组。重新标测组中记录有不完全消融区域的患者接受递增消融灶以实现完全消融。主要终点是无复发生存率。
共纳入588例患者,平均随访25.8个月。243例患者接受了PVI后重新标测,而345例患者接受了传统PVI。与传统PVI相比,PVI后重新标测及引导下递增消融灶改善了无复发生存率(调整后风险比0.75,95%置信区间[CI]0.57 - 0.99,P = 0.04)。这种益处在阵发性心房颤动患者中尤为显著(风险比0.69,95%CI 0.49 - 0.96,P = 0.027)。两组的并发症发生率和手术时间相当。对于首次接受射频消融的患者,接受PVI重新标测的患者1年成功率更高(调整后优势比1.70,95%CI 1.04 - 2.77,P = 0.03)。然而,两组的长期结局相当。
消融后标测有效地识别并处理致心律失常灶,可能降低心房颤动复发率并改善患者结局。